Altogether, our data indicate that TEL is the major TMM in the CRC cases studied, while the ALT pathway additionally activates mainly in MSI s-CRC due to the concerted action of a number of factors, among them the HR and APB TMM branches as the main drivers. The gene discussed is GPT; the disease is colorectal carcinoma.